Andrologie et gynécologie : recherches actuelles

Discovery of a New Anti Androgen Compound

Mustafa Pehlivan

Discovery of a New Anti Androgen Compound

Androgen receptor inhibitors reduce or eliminate symptoms of prostate cancer by inhibiting Androgen receptors. The main advantage of this new compound is that it does not block any other receptors except androgen, and therefore it is very specific. Also another advantage of it in terms of its mechanism of inhibition is that its inhibition efficacy is about 90%, and therefore it would be a very efficient anti-cancer drug for prostate cancer and related diseases. Also when compared to other anti-Androgen drugs, this drug has a different and better enzalutamide activity.